Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights

Go back to Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights

Aldeyra Therapeutics (ALDX) Misses Q3 EPS by 1c

October 28, 2021 7:03 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More